Key facts
- Bainbridge Health’s last known valuation is $29.0M (May 2025).
- It has raised $9.7M across 4 recorded rounds; the latest was Seed Round ($3.4M) in Apr 2025.
- Notable investors include Alumni Ventures, Chestnut Street Ventures, Ben Franklin Technology Partners of Southeastern Pennsylvania, BioAdvance Capital (Conshohocken), Brainchild (Management Consulting) — 7 tracked in total.
- Bainbridge Health has filed 4 Form Ds with the SEC since 2017, most recently May 2025 ($3.4M sold to 6 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Bainbridge Health
Funding rounds
4 roundsAbout Bainbridge Health
Developer of a medication safety platform designed to reduce medication errors. The company's platform provides a vendor-agnostic medication safety platform that puts an end to pivot tables, ad-hoc dashboard requests, and manually-intensive data clerking, enabling hospitals and clinicians to improve patient safety and reduce avoidable costs for hospitals by mitigating the risk of medication errors.
- Sector
- Healthcare
- HQ
- Philadelphia, PA, United States
- Founded
- 2016
- Employees
- 26
- Website
- bainbridgehealth.com/
- Ownership
- Privately Held (backing)
Bainbridge Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bainbridge Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bainbridge Health in its N-PORT filings yet. We sweep new filings monthly.